OUD

Opioid Use Disorder in the Nursing Profession

Created by
International Nurses Society on Addictions (IntNSA)

Presented by Kristin Waite-Labott, RN, BSN, CARN; April Lynn Lenzmeier, RN, DNP; Rachel Shuster, BSN, RN, CARN, CAAP. The American Nurses Association estimates that six to eight percent of nurses use alcohol or drugs to an extent that is sufficient to impair professional performance. Others estimate that nurses generally misuse drugs and alcohol at nearly the same rate (10 to 15 percent) as the rest of the population.

The Intersection of DEA, Opioids, and MAT

Online,

Wednesday, April 27, 2022 @ 3:00-4:00pm ET (2CT/1MT/12PT)

Description

As a result of the opioid crisis, more and more primary care providers are being asked to treat those suffering from opioid use disorder (OUD) through the use of medication assisted treatment (MAT).

High-dose buprenorphine induction in the emergency department for treatment of opioid use disorder

Herring AA, Vosooghi AA, Luftig J, et al. High-Dose Buprenorphine Induction in the Emergency Department for Treatment of Opioid Use Disorder. JAMA Netw Open. 2021;4(7):e2117128. doi:10.1001/jamanetworkopen.2021.17128
Publication Date

Abstract

Importance: Emergency departments (EDs) sporadically use a high-dose buprenorphine induction strategy for the treatment of opioid use disorder (OUD) in response to the increasing potency of the illicit opioid drug supply and commonly encountered delays in access to follow-up care.

Is telemedicine the answer to rural expansion of medication treatment for opioid use disorder? Early experiences in the feasibility study phase of a National Drug Abuse Treatment Clinical Trials Network Trial

Hser, YI., Ober, A.J., Dopp, A.R. et al. Is telemedicine the answer to rural expansion of medication treatment for opioid use disorder? Early experiences in the feasibility study phase of a National Drug Abuse Treatment Clinical Trials Network Trial. Addict Sci Clin Pract 16, 24 (2021). https://doi.org/10.1186/s13722-021-00233-x
Publication Date
Abstract

Telemedicine (TM) enabled by digital health technologies to provide medical services has been considered a key solution to increasing health care access in rural communities.

Plausibility of patient-centred care in high-intensity methadone treatment: Reflections of providers and patients

Marshall, K., Maina, G. & Sherstobitoff, J. Plausibility of patient-centred care in high-intensity methadone treatment: reflections of providers and patients. Addict Sci Clin Pract 16, 42 (2021). https://doi.org/10.1186/s13722-021-00251-9
Publication Date

Abstract

Background: Patients with opioid use disorder (OUD) often have complex health care needs. Methadone is one of the medications for opioid use disorder (MOUD) used in the management of OUDs. Highly restrictive methadone treatment—which requires patient compliance with many rules of care—often results in low retention, especially if there is inadequate support from healthcare providers (HCPs).

Development of an unannounced standardized patient protocol to evaluate opioid use disorder treatment in pregnancy for American Indian and rural communities

Kelley, A.T., Smid, M.C., Baylis, J.D. et al. Development of an unannounced standardized patient protocol to evaluate opioid use disorder treatment in pregnancy for American Indian and rural communities. Addict Sci Clin Pract 16, 40 (2021). https://doi.org/10.1186/s13722-021-00246-6
Publication Date

Abstract

Background: Opioid use disorder (OUD) disproportionately impacts rural and American Indian communities and has quadrupled among pregnant individuals nationwide in the past two decades. Yet, limited data are available about access and quality of care available to pregnant individuals in rural areas, particularly among American Indians (AIs).

Patient-Reported Outcomes of Treatment of Opioid Dependence With Weekly and Monthly Subcutaneous Depot vs Daily Sublingual Buprenorphine: A Randomized Clinical Trial

Lintzeris N, Dunlop AJ, Haber PS, et al. Patient-Reported Outcomes of Treatment of Opioid Dependence With Weekly and Monthly Subcutaneous Depot vs Daily Sublingual Buprenorphine: A Randomized Clinical Trial. JAMA Netw Open. 2021;4(5):e219041. doi:10.1001/jamanetworkopen.2021.9041
Publication Date

Abstract

Importance: Patient-reported outcomes in the treatment of opioid dependence may differ between subcutaneously administered depot buprenorphine and daily sublingual buprenorphine.

Objective: To compare patient satisfaction between depot buprenorphine and sublingual buprenorphine in adult outpatients with opioid dependence.

The “Black Box” of Treatment: Patients’ Perspective on What Works in Opioid Maintenance Treatment for Opioid Dependence

Silva, T.C., Andersson, F.B. The “black box” of treatment: Patients’ perspective on what works in opioid maintenance treatment for opioid dependence. Subst Abuse Treat Prev Policy 16, 41 (2021). https://doi.org/10.1186/s13011-021-00378-7
Publication Date

Source:

Silva, T.C., Andersson, F.B. The “black box” of treatment: Patients’ perspective on what works in opioid maintenance treatment for opioid dependence. Subst Abuse Treat Prev Policy 16, 41 (2021). https://doi.org/10.1186/s13011-021-00378-7

 

The Role of Cannabis Use in Suicidal Ideation Among Patients With Opioid Use Disorder

Naji, L., Rosic, T., Sanger, N., Dennis, B., Worster, A., Paul, J., ... & Samaan, Z. (2020). The Role of Cannabis Use in Suicidal Ideation Among Patients With Opioid Use Disorder. Journal of addiction medicine.

Source:

Naji, L., Rosic, T., Sanger, N., Dennis, B., Worster, A., Paul, J., ... & Samaan, Z. (2020). The Role of Cannabis Use in Suicidal Ideation Among Patients With Opioid Use Disorder. Journal of addiction medicine.